Vaseem Khatri

Patients can benefit from SBRT / PBT over TACE in HCC (ineligible for upfront surgery/transplant) ! 🚨 Local Control HR 0.16 (0.08, 0.34) 🚨 💥 PFS HR 0.37 (0.23, 0.60) 💥 OS RR 0.79 (0.51, 1.22) Toxicity RR 0.86 (0.31, 2.37)

Thanks Dr. Ahmed @DrVogelbaum & @MoffittNews colleagues important addition to literature 1 yr LC 94% 44% SRS sessions concurrent, 56% delivered sequentially prior to tucatinib initiation Tucatinib is a HER2-targeted TKI Study particularly relevant w/common use HER2-CLIMB regimen

Is SRS WITH tucatinib for brain mets safe? Based on this study, Yes. · 135 lesions SRS · 4% symptomatic radiation necrosis rdcu.be/dihvn

We cannot wait welcome our newest class of residents @MoffittNews! Congratulations to Emily Keit MD, Vaseem Khatri MD, and @NakashimaJustyn DO! #RadOnc #MatchDay2021 @JessicaFrakesMD @SA_Rosenberg